During cancer treatment, the PI3K/Akt signaling pathway is often targeted to inhibit cancer cell proliferation; for example, the signaling pathway is controlled by the inhibition of lncRNA TDRG1 expression in osteosarcoma cells, thus interfering with their proliferation.131. The gene discussed is PIK3CB; the disease is cancer.